On June 7, 2021 the FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s. The first new treatment in over 17 years, its approval has not come without controversy.
Read moreOn June 7, 2021 the FDA approved Aduhelm (aducanumab) for the treatment of Alzheimer’s. The first new treatment in over 17 years, its approval has not come without controversy.
Read more